ESR1 and neoplasm: Over 75% of BCs express estrogen receptor (ER) in >1% of the tumor cells by immunohistochemistry (IHC) 2 and overlap with luminal A and B subtypes defined by global gene expression 3, 4 exhibiting low versus high proliferative indices and distant recurrence rates 5.